Heron Therapeutics (HRTX) EVP acquires 3,874 shares; holds 154,509
Heron Therapeutics (HRTX) reported an insider equity change.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Heron Therapeutics (HRTX) reported an insider equity change. EVP & Chief Development Officer William P. Forbes acquired 3,874 shares of common stock on 10/19/2025 via the conversion of restricted stock units (transaction code M). Following this event, he directly owns 154,509 shares of common stock. The filing also lists 34,869 derivative securities remaining as restricted stock units. Each RSU equals one share, and the RSUs vest in 16 equal quarterly installments beginning one quarter after 01/19/2024.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 3,874 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,874 | $0.00 | $0.00 |
Footnotes (2)
- F1. Each restricted stock unit represents a contingent right to receive one share of common stock.
- F2. The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024).
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did HRTX report?
What RSUs remain for William P. Forbes at HRTX?
How do the HRTX RSUs vest for this grant?
What does transaction code M mean in this context?
AI-generated analysis. How Rhea-AI works. Not financial advice.